205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-24.91%
Both yoy net incomes decline, with MRVL at -384.87%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-9.09%
Both reduce yoy D&A, with MRVL at -1.39%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
1350.00%
Well above MRVL's 2437.04% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-14.58%
Negative yoy SBC while MRVL is 0.68%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
62.22%
Slight usage while MRVL is negative at -145.36%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
248.05%
AR growth while MRVL is negative at -259.40%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
No Data
No Data available this quarter, please select a different quarter.
-200.00%
Both negative yoy AP, with MRVL at -227.62%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
8.75%
Some yoy usage while MRVL is negative at -53.18%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-195.65%
Both negative yoy, with MRVL at -24.67%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-11.95%
Both yoy CFO lines are negative, with MRVL at -64.38%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-9.40%
Both yoy lines negative, with MRVL at -29.61%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
9.40%
Less M&A spending yoy vs. MRVL's 100.00%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
-109.94%
Both yoy lines negative, with MRVL at -100.00%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
38.64%
We have some liquidation growth while MRVL is negative at -100.00%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-5.41%
We reduce yoy other investing while MRVL is 582.48%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-110.18%
We reduce yoy invests while MRVL stands at 1101.72%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-75.26%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-7.24%
We cut yoy buybacks while MRVL is 7.34%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.